The University of Chicago Header Logo

Connection

James Millis to Graft Rejection

This is a "connection" page, showing publications James Millis has written about Graft Rejection.
Connection Strength

1.436
  1. De novo sirolimus and reduced-dose tacrolimus versus standard-dose tacrolimus after liver transplantation: the 2000-2003 phase II prospective randomized trial. Am J Transplant. 2014 Feb; 14(2):356-66.
    View in: PubMed
    Score: 0.316
  2. Treatment of liver allograft rejection. Liver Transpl Surg. 1999 Jul; 5(4 Suppl 1):S98-S106.
    View in: PubMed
    Score: 0.115
  3. Cyclosporine versus cyclosporine microemulsion in pediatric liver transplant recipients. Transplant Proc. 1998 Jun; 30(4):1435-6.
    View in: PubMed
    Score: 0.107
  4. Tacrolimus treatment of steroid-resistant rejection provides economic advantages compared with OKT3 therapy. Transplant Proc. 1997 Feb-Mar; 29(1-2):1549.
    View in: PubMed
    Score: 0.097
  5. Treatment of steroid-resistant rejection with tacrolimus prior to OKT3 in liver transplant recipients. Transplant Proc. 1996 Apr; 28(2):1014.
    View in: PubMed
    Score: 0.092
  6. Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection. Liver Transpl. 2012 Jun; 18(6):716-26.
    View in: PubMed
    Score: 0.070
  7. Use of immune function test in monitoring immunosuppression in liver transplant recipients. Clin Transplant. 2012 Nov-Dec; 26(6):826-32.
    View in: PubMed
    Score: 0.070
  8. Randomized prospective trial of OKT3 for early prophylaxis of rejection after liver transplantation. Transplantation. 1989 Jan; 47(1):82-8.
    View in: PubMed
    Score: 0.056
  9. Risk factors for chronic rejection after pediatric liver transplantation. Transplantation. 2001 Sep 27; 72(6):1098-102.
    View in: PubMed
    Score: 0.034
  10. Modern immunosuppression. Clin Liver Dis. 2000 Aug; 4(3):619-55, ix.
    View in: PubMed
    Score: 0.031
  11. Tacrolimus therapy for refractory acute renal allograft rejection: a 4-year experience with an aggressive approach. Transplant Proc. 1998 Jun; 30(4):1234-5.
    View in: PubMed
    Score: 0.027
  12. Reversal of delayed hyperacute renal allograft rejection with a tacrolimus-based therapeutic regimen. Transplant Proc. 1998 Jun; 30(4):1249-50.
    View in: PubMed
    Score: 0.027
  13. Effects of tacrolimus, mycophenolate mofetil, and cyclosporine microemulsion on rejection incidence in synchronous pancreas-kidney transplantation. Transplant Proc. 1998 Mar; 30(2):507-8.
    View in: PubMed
    Score: 0.026
  14. Liver transplantation for the treatment of urea cycle disorders. J Inherit Metab Dis. 1998; 21 Suppl 1:112-8.
    View in: PubMed
    Score: 0.026
  15. Reversal of accelerated renal allograft rejection with FK 506. Clin Transplant. 1997 Aug; 11(4):251-4.
    View in: PubMed
    Score: 0.025
  16. Tacrolimus therapy for refractory renal allograft rejection: experience with steroid withdrawal. Transplant Proc. 1997 Feb-Mar; 29(1-2):307.
    View in: PubMed
    Score: 0.024
  17. Tacrolimus therapy for refractory acute renal allograft rejection: definition of the histologic response by protocol biopsies. Transplantation. 1996 Oct 15; 62(7):906-10.
    View in: PubMed
    Score: 0.024
  18. FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation. Clin Transplant. 1996 Aug; 10(4):323-32.
    View in: PubMed
    Score: 0.023
  19. OKT3 escalating dose regimens provide effective therapy for renal allograft rejection. Clin Transplant. 1996 Aug; 10(4):389-95.
    View in: PubMed
    Score: 0.023
  20. Tacrolimus for primary treatment of steroid-resistant hepatic allograft rejection. Transplantation. 1996 May 15; 61(9):1365-9.
    View in: PubMed
    Score: 0.023
  21. Role of protocol biopsies in the treatment of refractory renal allograft rejection with FK 506. Transplant Proc. 1996 Apr; 28(2):998-9.
    View in: PubMed
    Score: 0.023
  22. Living-donor liver transplantation at UCLA. Am J Surg. 1995 May; 169(5):529-32.
    View in: PubMed
    Score: 0.022
  23. The role of tumor necrosis factor in allograft rejection. III. Evidence that anti-TNF antibody therapy prolongs allograft survival in rats with acute rejection. Transplantation. 1991 Jan; 51(1):57-62.
    View in: PubMed
    Score: 0.016
  24. Outcomes of kidney transplantation in HIV-infected recipients. N Engl J Med. 2010 Nov 18; 363(21):2004-14.
    View in: PubMed
    Score: 0.016
  25. The role of tumor necrosis factor in allograft rejection. II. Evidence that antibody therapy against tumor necrosis factor-alpha and lymphotoxin enhances cardiac allograft survival in rats. Transplantation. 1990 Aug; 50(2):189-93.
    View in: PubMed
    Score: 0.015
  26. The role of tumor necrosis factor in allograft rejection. I. Evidence that elevated levels of tumor necrosis factor-alpha predict rejection following orthotopic liver transplantation. Transplantation. 1990 Aug; 50(2):219-25.
    View in: PubMed
    Score: 0.015
  27. Preservation of renal function using OKT3 in liver transplant patients. Transplant Proc. 1989 Jun; 21(3):3551-2.
    View in: PubMed
    Score: 0.014
  28. The successful use of repeated courses of OKT3 for hepatic allograft rejection using %T3 cells to adjust dose. Transplant Proc. 1989 Feb; 21(1 Pt 2):2247-8.
    View in: PubMed
    Score: 0.014
  29. Combined liver and kidney transplantation in children. Transplantation. 2000 Jul 15; 70(1):100-5.
    View in: PubMed
    Score: 0.008
  30. Liver transplantation in the first three months of life. Transplantation. 1998 Sep 15; 66(5):606-9.
    View in: PubMed
    Score: 0.007
  31. Tacrolimus/mycophenolate provides superior immunosuppression relative to neoral/mycophenolate in synchronous pancreas-kidney transplantation. Transplant Proc. 1998 Jun; 30(4):1538-40.
    View in: PubMed
    Score: 0.007
  32. An analysis of hepatic retransplantation in children. Transplantation. 1998 May 15; 65(9):1172-8.
    View in: PubMed
    Score: 0.007
  33. Retransplantation for failed hepatic allografts in children. Transplant Proc. 1997 Feb-Mar; 29(1-2):442-3.
    View in: PubMed
    Score: 0.006
  34. Small intestine transplantation at the University of California, Los Angeles. Transplant Proc. 1996 Oct; 28(5):2746-7.
    View in: PubMed
    Score: 0.006
  35. Long-term outcome of kidney-pancreas transplant recipients with good graft function at one year. Transplantation. 1996 Aug 27; 62(4):451-6.
    View in: PubMed
    Score: 0.006
  36. Late complications in kidney-pancreas transplant recipients. Transplant Proc. 1995 Dec; 27(6):3118.
    View in: PubMed
    Score: 0.006
  37. Lack of correlation between the magnitude of preservation injury and the incidence of acute rejection, need for OKT3, and conversion to FK506 in cyclosporine-treated primary liver allograft recipients. Transplantation. 1995 Sep 27; 60(6):554-8.
    View in: PubMed
    Score: 0.006
  38. Liver transplantation in children. Ann Surg. 1991 Jan; 213(1):48-57.
    View in: PubMed
    Score: 0.004
  39. The importance of percutaneous liver biopsy in the management of the liver transplant recipient. Transplant Proc. 1988 Feb; 20(1 Suppl 1):682-4.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.